| Safety assessment of intraportal liver cell application in New Zealand white rabbits under GLP conditions. | |
| | |
MedLine Citation:
|
PMID: 22532025 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Liver cell transplantation (LCT) is considered a new therapeutic strategy for the treatment of acute liver failure and inborn metabolic defects of the liver. Although minimally invasive, known safety risks of the method include portal vein thrombosis and pulmonary embolism. Since no systematic data on these potential side effects exist, we investigated the toxicological profile of repeated intraportal infusion of allogeneic liver cells in 30 rabbits under GLP conditions. Rabbit liver cells were administered once daily for 6 consecutive days at 3 different dose levels, followed by a 2-week recovery period. No test item-related mortality was observed. During cell infusion, clinical findings such as signs of apathy and hyperventilation, moderate elevations of liver enzymes ALT and AST and a slight decrease in AP were observed, all fully reversible. Cell therapy-related macroscopic and histological findings, especially in liver and lungs, were observed in animals of all dose groups. In conclusion, the liver and lungs were identified as potential toxicological target organs of intraportal allogeneic liver cell infusion. A NOAEL (no observed adverse effect level) was not defined because of findings observed also in the low-dose group. No unexpected reactions became apparent in this GLP study. Overall, LCT at total doses up to 12 % (2 % daily over 6 days) of the total liver cell count were tolerated in rabbits. Observed adverse effects are not considered critical for treatment in the intended patient populations provided that a thorough monitoring of safety relevant parameters is in place during the application procedure. |
| | |
Authors:
|
S Kafert-Kasting; A Schneider; M Attaran; C Priesner; M Barthold; A L Perrier; H Kriegbaum; M Ott; J Meyburg |
Related Documents
:
|
3677055 - Irreversible inhibition of the cytosolic metabolism of n-hydroxy-2-acetylaminofluorene ... 6855465 - Microsomal and cytosolic epoxide hydrolases in rhesus monkey liver, and in normal and n... 3971365 - Metabolism of nitrosamines by purified rabbit liver cytochrome p-450 isozymes. 8074455 - Effects of isothiocyanates on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-b... 10072335 - Demonstration of the contact sensitizer p-tert-butylcatechol in p-tert-butylphenol form... 20738635 - Postprandial metabolic increment of southern bluefin tuna thunnus maccoyii ingesting hi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-25 |
Journal Detail:
|
Title: Archives of toxicology Volume: - ISSN: 1432-0738 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0417615 Medline TA: Arch Toxicol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Research and Development, Cytonet GmbH & Co. KG, 30625, Hannover, Germany, sabine.kafert-kasting@cytonet.de. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies.
Next Document: Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary...